Table 2.
Multivariable Cox regression for clinical outcomes in COVID-19 patients.
Variable | β | HR (95% CI) | p |
---|---|---|---|
Sex | − 0.186 | 1.204 (0.936–1.548) | 0.148 |
Age (≤ 50/ > 50) | 0.432 | 0.649 (0.451–0.933) | 0.020 |
Chronic kidney disease | 0.109 | 0.897 (0.671–1.200) | 0.464 |
Chronic liver disease | − 0.161 | 1.175 (0.702–1.965) | 0.540 |
Hypertension | 0.381 | 0.683 (0.485–0.963) | 0.030 |
Diabetes | 0.240 | 0.786 (0.604–1.023) | 0.074 |
Cardiovascular disease | 0.359 | 0.698 (0.537–0.907) | 0.007 |
Malignancy | 0.490 | 0.613 (0.446–0.841) | 0.002 |
Liver injury | 0.919 | 2.506 (1.913–3.285) | < 0.001 |